2020
Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging
Mur T, Sambhu KM, Mahajan A, Payabvash S, Fernandez J, Edwards HA. Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging. American Journal Of Otolaryngology 2020, 41: 102662. PMID: 32858370, DOI: 10.1016/j.amjoto.2020.102662.Peer-Reviewed Original ResearchConceptsPET/CTLow-dose nonenhanced CTDistant metastasisChest CTNeck cancerNonenhanced CTF-fluorodeoxyglucose positron emission tomographyF-FDG PET/CTDiagnostic chest CTDistant metastatic diseaseInitiation of therapyRetrospective cohort studyPre-treatment stagingTertiary care settingSignificant differencesPositron emission tomographyMetastatic diseaseCohort studyOncologic treatmentTNM stagingInaccurate stagingNeck radiologistsCare settingsSingle patientPatientsApplications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
Haider SP, Burtness B, Yarbrough WG, Payabvash S. Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas. Cancers Of The Head & Neck 2020, 5: 6. PMID: 32391171, PMCID: PMC7197186, DOI: 10.1186/s41199-020-00053-7.Peer-Reviewed Original ResearchNeck squamous cell carcinomaSquamous cell carcinomaCell carcinomaPatient selectionNeck cancerClinical trialsObjective biomarkersRoutine clinical applicationPrognostic biomarkerTreatment guidancePersonalized treatmentRadiomics analysisTreatment planningPrecision medicineClinical applicationCarcinomaPrecision diagnosisApplication of radiomicsPrognosticationBiomarkersRadiomicsHeadCancerDiagnosisTrials
2018
Quantitative diffusion magnetic resonance imaging in head and neck tumors
Payabvash S. Quantitative diffusion magnetic resonance imaging in head and neck tumors. Quantitative Imaging In Medicine And Surgery 2018, 8: 1052-1065. PMID: 30598882, PMCID: PMC6288053, DOI: 10.21037/qims.2018.10.14.Peer-Reviewed Original ResearchNeck tumorsMagnetic resonance imaging (MRI) scansPrimary malignant processMetastatic lymph nodesResonance imaging scansQuantitative diffusion magnetic resonanceAnatomical magnetic resonance imaging scanLymph nodesPrimary lesionNeck cancerImaging scansTreatment responseMalignant processTumor pathologyPosttreatment changesDiffusion magnetic resonanceDiffusion MRIPrognostic predictionAnatomical evaluationPrimary malignant tissueQuantitative diffusion MRITreatment monitoringMalignant tissuesPatientsTumors
2015
Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging
Payabvash S, Meric K, Cayci Z. Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging. Clinical Imaging 2015, 40: 101-105. PMID: 26454617, DOI: 10.1016/j.clinimag.2015.09.001.Peer-Reviewed Original ResearchMeSH KeywordsDiagnosis, DifferentialFemaleFluorodeoxyglucose F18Head and Neck NeoplasmsHumansImage-Guided BiopsyLymph NodesLymphatic DiseasesLymphatic MetastasisMaleMiddle AgedMultimodal ImagingNeckPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesSensitivity and SpecificityTomography, X-Ray ComputedConceptsHead/neck cancerCervical lymph nodesMalignant cervical lymph nodesLymph nodesNeck cancerPositron emission tomographySUV maxHigh maximum standardized uptake valueBenign cervical lymph nodesMaximum standardized uptake valueLymph node biopsyMalignant lymph nodesMalignant cervical lymphadenopathyPET/CT imagingStandardized uptake valueSUV max valuesShort-axis diameterCervical lymphadenopathyNode biopsyMalignant lymphadenopathyRetrospective studyPatientsUptake valueEmission tomographyCancer